KLOW peptide blend is Alpha Tides’ proprietary quad-peptide research compound, combining four well-studied compounds into a single lyophilized vial. Each peptide in the KLOW peptide blend operates through a distinct biological pathway, making it a subject of interest for researchers studying tissue repair, inflammatory signaling, and cellular regeneration simultaneously across multiple mechanisms.
The Four Components
GHK-Cu is a naturally occurring copper-binding tripeptide found in human plasma. Research has focused on its role in wound healing, collagen synthesis, and tissue remodeling. It is among the most studied peptides in skin and connective tissue research, with a body of preclinical literature spanning several decades.
BPC-157 is a 15-amino acid peptide originally derived from human gastric juice. Preclinical research across multiple studies has shown improved outcomes in inflammatory bowel disease, GI ulcer, NSAID-induced injury, and wound repair models. It has also attracted attention in musculoskeletal research for its influence on angiogenesis and tissue regeneration.
TB-500 is a synthetic analog of Thymosin Beta-4, a naturally occurring peptide involved in actin regulation and cell migration. It has been studied in preclinical models for its role in tissue repair, particularly in contexts involving muscle, tendon, and vascular tissue. Its mechanism centers on promoting cell migration and reducing inflammation at injury sites.
KPV is a tripeptide fragment derived from alpha-melanocyte-stimulating hormone. Research has shown that KPV inhibits key intracellular signaling pathways central to inflammatory responses, including the NF-kB and MAPK cascades, as well as the subsequent synthesis of pro-inflammatory cytokines. It has also been studied for its potential role in gut barrier integrity and skin inflammation models.
Why Four Compounds
Each peptide in KLOW peptide blend addresses a different stage of the inflammatory and repair cascade. GHK-Cu supports structural remodeling, BPC-157 promotes vascular and tissue regeneration, TB-500 facilitates cell migration, and KPV targets upstream inflammatory signaling. Researchers studying multi-pathway interactions in repair models may find the KLOW peptide blend useful for examining how these mechanisms interact under controlled experimental conditions.
About Alpha Tides KLOW Peptide Blend
KLOW peptide blend is formulated and quality-verified for research applications requiring multi-pathway analysis. Each batch of KLOW peptide blend undergoes third-party testing through Janoshik Analytical to confirm compound identity and concentration across all four components. This level of verification is essential for researchers who need confidence in the exact composition of their experimental materials. Unlike single-compound vials, KLOW peptide blend provides a ready-formulated combination that eliminates the need to source and combine four separate peptides individually — reducing preparation time and potential for cross-contamination in laboratory settings.
Researchers working with KLOW peptide blend should note that each component has its own documented mechanism and receptor interaction profile. Experimental design should account for the multi-pathway nature of the blend, particularly when comparing results against single-compound controls. Full component specifications and third-party COA documentation are available upon request.
Product Details
- Form: Lyophilized powder blend
- Total contents: 80mg per vial
- Breakdown: GHK-Cu / BPC-157 / TB-500 / KPV
- Purity: 99% per component | Third-party COA verified (Janoshik, Batch 635966)
- Storage: Keep dry and away from light before reconstitution. Refrigerate after reconstitution.
Research Use Only
KLOW peptide blend is intended strictly for laboratory research by qualified professionals. It is not FDA approved and is not for human or animal use. By purchasing, the buyer confirms the product will be used solely for in vitro research in compliance with all applicable laws and regulations.
Reviews
There are no reviews yet.